Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The study landscape for prostate cancer].

K Miller1

  • 1Urologische Klinik und Poliklinik, Charité Berlin. kurt.miller@charite.de

Der Urologe. Ausg. A
|November 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sometimes it really is appendicitis: case of a CML patient with acute appendicitis.

Annals of hematology·1998
Same author

Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans.

Antimicrobial agents and chemotherapy·1998
Same author

Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.

Leukemia research·1998
Same author

Determinants of increased energy expenditure in HIV-infected women.

The American journal of clinical nutrition·1998
Same author

Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

The Journal of clinical endocrinology and metabolism·1998
Same author

Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·1998

German prostate cancer research explores adjuvant therapy, rising PSA, and metastatic disease. Studies investigate zoledronic acid for bone metastasis prevention and imatinib for rising PSA post-prostatectomy.

Area of Science:

  • Oncology
  • Urology

Context:

  • Current prostate cancer research in Germany focuses on four key indications.
  • These include adjuvant therapy, rising PSA post-prostatectomy, metastatic hormone-sensitive, and hormone-refractory prostate cancer.

Purpose:

  • To investigate novel therapeutic strategies across different stages of prostate cancer.
  • Evaluating zoledronic acid for bone metastasis prevention in adjuvant settings.
  • Assessing imatinib efficacy in rising PSA patients post-prostatectomy.
  • Comparing intermittent versus continuous hormone therapy and chemotherapy regimens.

Summary:

  • Phase III trials are evaluating zoledronic acid for preventing bone metastases and comparing hormone therapy schedules.
  • Phase II trials assess imatinib for rising PSA and promising results in hormone-refractory prostate cancer (HRPC) are leading to phase III chemotherapy comparisons.

Related Experiment Videos

  • New protocols are under review for advanced prostate cancer treatment.

    • Impact:

    • These studies aim to improve treatment outcomes for various prostate cancer patient groups.
    • Advancing the understanding and management of prostate cancer in Germany.
    • Potential for new treatment guidelines and improved patient care.